Multi-omics, machine learning, and molecular simulation identify CD44 as a candidate target in endocrine-disrupting chemical-associated thyroid cancer progression.

Yi-Fan Hu Ke-Shu Liu Ting Chen Zhi-Zhen He Shuang Li Wu Hu Qiuyang Fu Xiong Chen

DOI PubMed Semantic Scholar